Log in

Sernova Stock Price, News & Analysis (CVE:SVA)

-0.02 (-8.33 %)
(As of 10/18/2019 04:00 PM ET)
Today's Range
Now: C$0.22
50-Day Range
MA: C$0.23
52-Week Range
Now: C$0.22
Volume738,700 shs
Average Volume414,646 shs
Market CapitalizationC$43.05 million
P/E RatioN/A
Dividend YieldN/A
Sernova Corp., a clinical-stage regenerative medicine therapeutics company, focuses on the development and commercializing of its proprietary Cell Pouch and associated technologies, including therapeutic cells and local immune protection. The company is developing a Cell Pouch system that is in Phase I/II clinical trial for the treatment of type-1 diabetes. Its Cell Pouch system is a medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells for the treatment of chronic diseases, such as hemophilia A and thyroid diseases. Sernova Corp. is headquartered in London, Canada.

Industry, Sector and Symbol

Industry Diagnostics & Research



Sales & Book Value

Annual SalesN/A
Cash FlowC$0.01 per share
Book ValueC$0.01 per share



Market CapC$43.05 million
Next Earnings Date2/21/2020 (Estimated)

Receive SVA News and Ratings via Email

Sign-up to receive the latest news and ratings for SVA and its competitors with MarketBeat's FREE daily newsletter.

Sernova (CVE:SVA) Frequently Asked Questions

What is Sernova's stock symbol?

Sernova trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SVA."

How were Sernova's earnings last quarter?

Sernova Corp. (CVE:SVA) announced its quarterly earnings data on Monday, September, 30th. The company reported ($0.01) earnings per share (EPS) for the quarter. View Sernova's Earnings History.

When is Sernova's next earnings date?

Sernova is scheduled to release their next quarterly earnings announcement on Friday, February 21st 2020. View Earnings Estimates for Sernova.

What is the consensus analysts' recommendation for Sernova?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sernova in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Sernova.

Has Sernova been receiving favorable news coverage?

Media headlines about SVA stock have trended somewhat positive recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Sernova earned a news sentiment score of 0.8 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Sernova.

Who are some of Sernova's key competitors?

What other stocks do shareholders of Sernova own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sernova investors own include Nemaska Lithium (NMX), Canarc Resource (CCM), CorMedix (CRMD) and Intercept Pharmaceuticals (ICPT).

How do I buy shares of Sernova?

Shares of SVA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Sernova's stock price today?

One share of SVA stock can currently be purchased for approximately C$0.22.

How big of a company is Sernova?

Sernova has a market capitalization of C$43.05 million. View Additional Information About Sernova.

What is Sernova's official website?

The official website for Sernova is http://www.sernova.com/.

How can I contact Sernova?

Sernova's mailing address is 700 Collip Cir Suite 114, LONDON, ON N6G 4X8, Canada. The company can be reached via phone at +1-519-8585184.

MarketBeat Community Rating for Sernova (CVE SVA)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  37 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  79
MarketBeat's community ratings are surveys of what our community members think about Sernova and other stocks. Vote "Outperform" if you believe SVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel